About Symed Labs Limited
Data last updated:
Symed Labs Limited was a public limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Viyash Life Sciences Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 August 1998.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1998PLC029961. Its GSTIN is 36AADCS5186M1ZS (Telangana). The company held 4 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹93.01 Lakh. It was formerly known as Symed Labs Private Limited. It was led by directors including Hari Babu Bodepudi and Kalidindi Srihari Raju.
Its last annual general meeting (AGM) was held on 18 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹791.92 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹120.48 Cr (net margin 15.2%) and EBITDA of ₹182.54 Cr (EBITDA margin 23.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 11% over five years.
The company had about 949 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Symed. As per MCA filings, the company had open charges of ₹250.58 Cr and satisfied charges of ₹171.04 Cr on record. Court records list 54 cases involving the company, including 32 filed by the company and 22 filed against it; 7 cases are pending. The company has 9 deals on record (9 secondary share transfers); the latest was in July 2024. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Andhra Organics Limited with revenue of ₹854.31 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 82 overdue payments to 21 micro and small suppliers.
The last known website on record is symedlabs.com.
Company details
CIN history
Symed Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG1998PLC029961, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1998PLC029961 | Current |
| U24231AP1998PLC029961 | Previous |
| L24231AP1998PLC029961 | Previous |
Contact details
Symed Labs Limited's registered office is in Hyderabad, Telangana. Its website is symedlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 290 Srivallis Corporate, Road No. 6 Kakatiya Hills, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Symed Labs Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Symed Labs operates one associated brand: Symed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs are manufactured and drug development services are provided. | symedlabs.com |
Business activity
The main business activity of Symed Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Symed Labs Limited, buy the company report.
Financials of Symed Labs Limited
FY 2025 filings availableSymed Labs Limited reported revenue of ₹791.92 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 6% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹182.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹120.48 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.1% | ||||
| Net Profit Margin | 15.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symed Labs Limited, buy the company report.
Board of directors of Symed Labs Limited
Symed Labs has 7 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Babu Bodepudi Also directs: Viyash Scientific Limited | Director | 07 Jul 2021 | 5 Years 4 Months | As last reported |
| Kalidindi Srihari Raju Also directs: Pokepola Enterprises LLP | Director | 07 Jul 2021 | 5 Years 4 Months | As last reported |
| Vijayalakshmi Vaithianathan Also directs: Alivira Animal Health Limited | Nominee Director | 07 Jul 2021 | 5 Years 4 Months | As last reported |
| Pradip Manilal Kanakia Also directs: Healthcare Global Enterprises Limited, Britannia Industries Ltd, Sona BLW Precision Forgings Limited and 5 more | Director | 04 Mar 2022 | 4 Years 8 Months | As last reported |
| Kamal Kishore Sharma Also directs: Templecraft Realty LLP, Templeriviere Property LLP, Temple Wellness Ventures LLP and 5 more | Director | 01 Dec 2022 | 3 Years 11 Months | As last reported |
| Anuj Vishnukumar Poddar | Director | 25 Jun 2025 | 1 Years 4 Months | As last reported |
Peer comparison
Symed Labs Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Andhra Organics Limited | ₹854.31 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Shilpa Pharma Lifesciences Limited | ₹849.95 Cr (FY 2025) | -1.0% | Raichur, Karnataka, India | |||
| India Pesticides Limited. | ₹843.44 Cr (FY 2025) | 21.0% | Uttar Pradesh, India | |||
| Virupaksha Organics Limited | ₹816.52 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Symed Labs Limitedthis company | ₹791.92 Cr (FY 2025) | ₹120.48 Cr | 15.2% | 6.0% | 949 | Hyderabad, Telangana, India |
| Sterile India Private Limited | ₹791.14 Cr (FY 2025) | -13.0% | New Delhi, Delhi, India | |||
| Symbiotec Pharmalab Limited | ₹755.98 Cr (FY 2025) | 5.0% | Mhow, Madhya Pradesh, India | |||
| Tagoor Laboratories Private Limited | ₹719.28 Cr (FY 2022) | 55.0% | Andhra Pradesh, India |
To see the full peer comparison of Symed Labs Limited, buy the company report.
Auditor
Symed Labs Limited is audited by Deloitte Haskins & Sells Chartered Accountants for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells Chartered Accountants | FY 2024 | 008072S |
Shareholding
The shareholding of Symed Labs Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Symed Labs Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2017 | 100129343 | Yes Bank Limited | ₹10 Cr | Satisfied | |
| 08 Feb 2016 | 100017950 | Tata Cleantech Capital Limited | ₹20 Cr | Satisfied | |
| 13 Jun 2013 | 10434059 | State Bank of Mysore | ₹5.75 Cr | Satisfied | |
| 27 Sep 2011 | 10317507 | Andhra Bank | ₹2 Cr | Satisfied | |
| 06 May 2011 | 10290841 | Andhra Bank | ₹3 Cr | Satisfied |
To see the full charge records of Symed Labs Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Symed Labs Limited has 9 deals on record (9 secondary share transfers); the latest was in July 2024.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2024 | Secondary share transfer | Undisclosed | Buyer: Viyash Life Sciences Private Limited Seller: M Krishna Sindhuri Private Trust, 3 individuals |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: Viyash Life Sciences Private Limited Seller: Sai Sindhu Foundation, 3 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Sai Sindhu Foundation Seller: Bandi Investments Private Limited, 2 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: Bandi Investments Private Limited, 2 individuals Seller: Sai Sindhu Foundation |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Sai Sindhu Foundation Seller: Bandi Investments Private Limited, 2 individuals |
To see the full deal history of Symed Labs Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Symed Labs Limited has 54 court cases on record: 32 filed by Symed Labs, 22 filed against it. 7 cases are pending and 47 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 40 | 14 | 7 |
| District courts | 14 | 8 | 0 |
Cases on record (5 of 54)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case (CMA(PT)) | Filed against the company by Optimus Drugs Pvt. Ltd, | Pending |
| Madras High Court | Interim or miscellaneous application | Filed against the company by Optimus Drugs Pvt. Ltd, | Pending |
| High Court | Court case ((T)OP(PT)) | Filed against the company by Centaurus Pharma Pvt Ltd., | Disposed |
| High Court | Court case ((T)OP(PT)) | Filed against the company by Usv Private Limited M/S. Lex Orbis Ip Practice, Petitioner - Notice Sent Service Awaited | Disposed |
| High Court, TAMIL NADU | Court case (WP(IPD)) | Filed against the company by Optimus Drugs Private Limited | Disposed |
To see the full case history of Symed Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Symed Labs Limited was last rated by Crisil on 18 Dec 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 18 Dec 2019 |
To see the full credit ratings and regulatory alerts of Symed Labs Limited, buy the company report.
MSME payment delays
Symed Labs Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 82 overdue payments to 21 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 21)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Savant Envitech Private Limited | |||
| Styrax Instruments India Private Limited | |||
| C.Abhaykumar & Co | |||
| Spincotech Private Limited | |||
| Pramog Labs Private Limited |
To see the full MSME payment records of Symed Labs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Symed Labs Limited has a workforce of 949 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Symed Labs has 4 GST registrations: 1 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCS5186M1ZS | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Symed Labs Limited, buy the company report.
Recent activity
Symed Labs Limited has 37 board changes on record since 2000: 22 appointments and 15 cessations. The latest: Anuj Vishnukumar Poddar was appointed as Director on 25 Jun 2025.
48 earlier events are in the company report.
Frequently asked questions
Symed Labs has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Symed Labs was a public limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 17 August 1998 and is registered under CIN U24231TG1998PLC029961. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Symed Labs was incorporated on 17 August 1998. It is registered with the Registrar of Companies, Hyderabad.
Symed Labs had 7 directors:
- Hari Babu Bodepudi - Director
- Kalidindi Srihari Raju - Director
- Vijayalakshmi Vaithianathan - Nominee Director
- Pradip Manilal Kanakia - Director
- Kamal Kishore Sharma - Director
- Anuj Vishnukumar Poddar - Director
- Srinivas Vasireddy - Director
The CIN (Corporate Identification Number) of Symed Labs is U24231TG1998PLC029961. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Symed Labs is at Plot No. 290 Srivallis Corporate, Road No. 6 Kakatiya Hills, Hyderabad, Telangana, India – 500081.
Symed Labs can be reached through the website symedlabs.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Symed Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Symed Labs is 36AADCS5186M1ZS, registered in Telangana. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
Symed Labs operated in the pharma industry, in the api manufacturers segment.
Symed Labs has 9 deals on record (9 secondary share transfers); the latest was in July 2024.
The peers of Symed Labs by revenue are Andhra Organics Limited, Shilpa Pharma Lifesciences Limited, India Pesticides Limited, Virupaksha Organics Limited, Sterile India Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
